← Leaderboards
Gregory S Martin
Emory University
$5,670,342
Attributed
$7,726,925
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $50.9M · FY2008–25$100M$75M$50M$25M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$99,652,198 · 8
FDA$1,050,000 · 1
By mechanism
U54$94,750,534 · 4
UM1$2,505,428 · 1
P50$1,407,391 · 1
R01$1,050,000 · 1
K23$633,820 · 1
R21$355,025 · 1
Top collaborators
- Wilbur A Lam14 shared
- Oliver Brand8 shared
- Eric M Vogel4 shared
- Alpha Alsbury Fowler3 shared
- Robert Duncan Hite3 shared
- Jonathon D Truwit3 shared
- Thomas R Ziegler2 shared
- Eric A Ortlund1 shared
Most similar at Emory University
Same institution · by research overlap
- Wilbur A Lam$39,688,140
- Eric M Vogel$0
- Stephanie Corinne Guerra$146,206
- Thomas R Ziegler$10,822,263
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsTranslationsClinical ResearchLungBaseEngineeringMicrosystemsResearch Clinical TestingHuman SubjectValidationAdoptionUniversity HospitalsCountryTechnologyHospitalsLung DiseasesDevicesUnited States National Institutes Of HealthChild Health CarePrototypePediatric HospitalsDiagnosticElectronicsInnovation
Grant awards (41)
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,561,849
U54 · FY2025 · EB
Clinical Core$237,186
U54 · FY2025 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,561,849
U54 · FY2024 · EB
Clinical Core$237,186
U54 · FY2024 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,618,350
U54 · FY2023 · EB
Clinical Core$251,313
U54 · FY2023 · EB · contact PI
ACME POCT EMERGENCY COVID-19 VARIANT TESTING & INDEPENDENT TEST ASSESSMENT EVALUATION SUPPLEMENT$15,864,683
U54 · FY2022 · EB
Emergency COVID-19 Variant Supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$15,481,896
U54 · FY2022 · EB
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,372,712
U54 · FY2022 · EB
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$648,527
U54 · FY2022 · EB
Clinical Translation and Validation Core$226,356
U54 · FY2022 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,373,615
U54 · FY2021 · EB
Clinical Translation and Validation Core$205,805
U54 · FY2021 · EB · contact PI
Emergency COVID-19 supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technoloites (ACME POCT)$31,080,737
U54 · FY2020 · EB
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$11,194,205
U54 · FY2020 · EB
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$7,085,000
U54 · FY2020 · EB
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,374,470
U54 · FY2020 · EB
Clinical Translation and Validation Core$205,805
U54 · FY2020 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,376,145
U54 · FY2019 · EB
Clinical Translation and Validation Core$205,805
U54 · FY2019 · EB · contact PI
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)$1,381,235
U54 · FY2018 · EB
Clinical Translation and Validation Core$205,805
U54 · FY2018 · HL · contact PI
Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury (CITRIS-ALI)$853,679
UM1 · FY2016 · HL
Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury (CITRIS-ALI)$881,978
UM1 · FY2014 · HL
Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury (CITRIS-ALI)$769,771
UM1 · FY2013 · HL
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury$275,000
R01 · FY2013 · FD · contact PI
Clinical Core$238,781
P50 · FY2013 · AA · contact PI
Clinical Core$278,772
P50 · FY2012 · AA · contact PI
HIGH-DOSE VITAMIN D AND ANTIMICROBIAL PEPTIDE EXPRESSION IN LUNG FAILURE$193,650
R21 · FY2012 · HL · contact PI
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury$75,000
R01 · FY2012 · FD · contact PI
Clinical Core$274,696
P50 · FY2011 · AA · contact PI
HIGH-DOSE VITAMIN D AND ANTIMICROBIAL PEPTIDE EXPRESSION IN LUNG FAILURE$161,375
R21 · FY2011 · HL · contact PI
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury$350,000
R01 · FY2010 · FD · contact PI
Clinical Core$312,206
P50 · FY2010 · AA · contact PI
Clinical Core$302,936
P50 · FY2009 · AA · contact PI
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury$350,000
R01 · FY2008 · FD · contact PI
ONCOTIC PRESSURE AND EXTRAVASCULAR LUNG WATER IN ARDS$127,220
K23 · FY2004 · HL
ONCOTIC PRESSURE AND EXTRAVASCULAR LUNG WATER IN ARDS$126,100
K23 · FY2003 · HL
ONCOTIC PRESSURE AND EXTRAVASCULAR LUNG WATER IN ARDS$125,905
K23 · FY2002 · HL
ONCOTIC PRESSURE AND EXTRAVASCULAR LUNG WATER IN ARDS$128,455
K23 · FY2001 · HL
ONCOTIC PRESSURE AND EXTRAVASCULAR LUNG WATER IN ARDS$126,140
K23 · FY2000 · HL